(Z)-2-(5-fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid-D3;(1Z)-5-Fluoro-2-methyl-1-[(4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic Acid-D3; cis-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidenyl]indene-3-acetic Acid-D3; Aflodac-D3; Algocetil-D3; Arthrocine-D3; Artribid-D3; Citireuma-D3; Clinoril-D3; Clisundac-D3; Imbaral-D3; Mobilin-D3; Reumofil-D3; Reumyl-D3; Sudac-D3; Sulindac-D3; Sulindac sulfoxide-D3; Sulinol-D3; Sulreuma-D3; cis-Sulindac-D3;
Sulindac-d3 is a fully characterized chemical compound used as a reference standard of API Sulindac. The standard offered is compliant with regulatory guidelines. Sulindac-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 38194-50-2 (non-labelled)
